Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Could the coronavirus cause the next ‘Arab Spring’?

The rich are getting richer, inequality is on the rise, and the middle class, the backbone of the US economy since the 1950s, is shrinking. In 2018 the three highest-paid chief executives in the United States earned more than the output of several countries. Tesla&Close...
Richard (Rick) Mills | March 19, 2020 |

The Narrative About Gold is Changing Again

Teaser: Let’s face it, we live in a world of radical uncertainty. Yet we’re supposed to make perfectly rational decisions – so, how do we cope with the unknown? We tell narratives, and form our decisions around them! Let’s...
Arkadiusz Sieron | December 2, 2019 |

Does Gold Really Care Whether Coronavirus Brings Us Deflation or Inflation?

One of the many bothering issues about the coronavirus crisis, is whether it will turn out to be inflationary or deflationary. What do both of these scenarios mean for gold ahead? US Inflation Rate Declines in March Many people are afraid that the coronavirus crisis wi...
Arkadiusz Sieron | April 16, 2020 |

Will the Fed Trigger Inflation This Time, Boosting Gold?

During Great Recession , many people feared that the Fed's quantitative easing would trigger high inflation , or even hyperinflation . As we know, it didn't happen. Why? Well, the main reason is that the Fed created money – that's true – but in the form of bank reserves. ...
Arkadiusz Sieron | May 29, 2020 |

The Gold Play That’s Poised for a Breakout 2022

With the spot price of gold hovering around USD$2000 and inflation soaring, savvy metals & mining investors are looking for real value and opportunity in the precious metals exploration space. And, it’s gold that has historically provided the most proven tra...
Dave Jackson | April 27, 2022 |

Reata Pharma Announces $350 Million Strategic Investment from Blackstone Life Sciences

Shares of Reata Pharmaceuticals traded 30% higher after reporting that Blackstone Life Sciences will invest $350 million in the company to advance bardoxolone methyl as a potential therapy for Alport syndrome and other rare and serious chronic kidney diseases. Clin...
Streetwise Reports | June 12, 2020 |

Is China locking up Indonesian nickel?

As it has done with cobalt , graphite and rare earths , China appears to be locking up the nickel market. Nickel’s top producer, Indonesia, in early September decided to accelerate a scheduled ban on ore export shipments, from 2022 to January 1, 2020. The...
Richard (Rick) Mills | November 6, 2019 |

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attr...
Mario Hose | April 16, 2020 |

HAVN Life Sciences: a biotech company developing technology-focused, data-driven psychedelic therapi

HAVN Life Sciences is a biotech company focused on psychedelic therapies. The Vancouver-based company develops technology-focused, data-driven, and medical-based solutions. Joining us here at the Top Line today is HAVN Life Sciences CEO, Tim Moore. Welcome back a...
Simon Druker | March 30, 2023 |

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...
Streetwise Reports | January 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...